Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort.
Thiruvengadam R, Ayushi, Murugesan DR, Desiraju BK, Misra S, Sharma D, Subbaian SS, Mehta U, Singh A, Sharma S, Khurana A, Mittal P, Chellani H, Bharti R, Tripathi R, Sopory S, Kshetrapal P, Salunke DM, Natchu UCM, Ramji S; GARBH-Ini study team; Wadhwa N, Bhatnagar S. Thiruvengadam R, et al. Among authors: murugesan dr. Lancet Glob Health. 2024 Aug;12(8):e1261-e1277. doi: 10.1016/S2214-109X(24)00212-2. Lancet Glob Health. 2024. PMID: 39030058 Free article.
The influence of drug class on reward in substance use disorders.
Jones JD, Arout CA, Luba R, Murugesan D, Madera G, Gorsuch L, Schusterman R, Martinez S. Jones JD, et al. Among authors: murugesan d. Pharmacol Biochem Behav. 2024 Jul;240:173771. doi: 10.1016/j.pbb.2024.173771. Epub 2024 Apr 24. Pharmacol Biochem Behav. 2024. PMID: 38670466 Review.
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation.
Binayke A, Zaheer A, Vishwakarma S, Singh S, Sharma P, Chandwaskar R, Gosain M, Raghavan S, Murugesan DR, Kshetrapal P, Thiruvengadam R, Bhatnagar S, Pandey AK, Garg PK, Awasthi A. Binayke A, et al. Among authors: murugesan dr. NPJ Vaccines. 2024 Jan 2;9(1):3. doi: 10.1038/s41541-023-00794-9. NPJ Vaccines. 2024. PMID: 38167915 Free PMC article.
Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity.
Thiruvengadam R, Rizvi ZA, Raghavan S, Murugesan DR, Gosain M, Dandotiya J, Ayushi, Samal S, Pandey AK, Wadhwa N, Bhatnagar S, Awasthi A, Garg PK. Thiruvengadam R, et al. Among authors: murugesan dr. Eur J Med Res. 2023 Oct 11;28(1):421. doi: 10.1186/s40001-023-01373-3. Eur J Med Res. 2023. PMID: 37821945 Free PMC article.
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
Batra G, Murugesan DR, Raghavan S, Chattopadhyay S, Mehdi F, Ayushi, Gosain M, Singh S, Das SJ, Deshpande S, Sonar S, Jakhar K, Bhattacharya J, Mani S, Pandey AK, Sankalp, Goswami S, Das A, Dwivedi T, Sharma N, Kumar S, Sharma P, Kapoor S, Kshetrapa P, Wadhwa N, Thiruvengadam R, Kumar R, Gupta R, Garg PK, Bhatnagar S. Batra G, et al. Among authors: murugesan dr. Indian J Med Res. 2023 Jun;157(6):509-518. doi: 10.4103/ijmr.ijmr_2521_22. Indian J Med Res. 2023. PMID: 37322634 Free PMC article.
27 results